REF 3050241

SARS-CoV-2 Detection and Monitoring Kit

Single-mix real-time RT-PCR for qualitative detection of SARS-CoV-2 RNA (ORF1ab and E regions) from respiratory specimens.

IVD-D CE Qualitative UMS Compatible · Multiplex · 1-mix · 1 target · 2-channel · 96-well · 24/48/96 reactions

Clinical Use

Qualitative detection of SARS-CoV-2 RNA in nucleic acid extracts from nasopharyngeal aspirate/lavage, bronchoalveolar lavage, nasopharyngeal swab, oropharyngeal swab and sputum samples. Designed for use by trained professional users in the clinical laboratory environment; results must be interpreted together with clinical findings, patient history, epidemiological information and other laboratory results.

This test is designed for qualitative detection. Cq values may be reported as supplementary information but must not be interpreted as a quantitative viral load.

Test Design

Target regionsSARS-CoV-2 ORF1ab & E (genome-specific primer-probe set)
Internal controlRNase P (co-amplification on HEX channel)
Format1-mix mastermix · 2-channel readout (FAM, HEX)
Reaction volume10 µL total
Cycle time~50 min
LoD (manual)250 SARS-CoV-2 copies/mL · 200 RFU threshold

Mix → Channel → Target Mapping

MixFAMHEXROXCy5Cy5.5
Mix 1SARS-CoV-2Internal Control

SARS-CoV-2 is detected on the FAM channel using a combined primer-probe set targeting the ORF1ab and E regions; the RNase P internal control is co-amplified on the HEX channel in every reaction. The single-mix design is compatible with all validated instruments calibrated for 2-channel (FAM, HEX) readout.

Kit Contents (24-reaction pack)

Oligo Mix1 × 24 µL · primer + probe (Mix 1)
Uniqplex Enzyme Mix1 × 120 µL
NTC1 × 1000 µL · negative template control
PC1 × 120 µL · reagent stability positive control

48- and 96-reaction packs are also available — see IFU §3.

Validated Instruments

  • Bio-Rad CFX96 Touch
  • HiMedia InstaQ96
  • Applied Biosystems QuantStudio 5
  • Qiagen Rotor-Gene Q 5plex

On QuantStudio 5 the HEX channel is reported as VIC — both labels refer to the same internal control fluorophore.

Performance

The LoD declared in the IFU for all kit versions is 250 SARS-CoV-2 copies/mL. Cross-reactivity has been tested against seasonal coronaviruses (229E, HKU1, NL63, OC43), MERS-CoV, SARS-CoV (2003), Influenza A and B, RSV, hMPV, Parainfluenza 1–4, Adenovirus, Rhinovirus, Enterovirus, M. pneumoniae, C. pneumoniae and S. pneumoniae; no cross-reactivity was observed. In-silico testing shows cross-reactivity with some bat-associated SARS-CoV strains (not clinically relevant).

Storage

Before use−20 °C · until expiry date
After opening−20 °C · 4 months (including freeze-thaw)
Freeze-thaw cycleMaximum 3

Regulatory

Class B IVD device. CE marked under the transitional provisions of Regulation (EU) 2017/746. The conformity assessment process under (EU) 2017/746 (IVDR) is ongoing. TİTCK registered. For in vitro diagnostic use only — for laboratory and professional use.